July 9, 2026 Apertura Gene Therapy Announces Cooperative Research and Development Agreement with Institutes of the NIH to Test Investigational Gene Therapy for Niemann-Pick Disease Type C1 — Cooperative Research and Development Agreement (CRADA) will utilize Apertura’s TfR1 CapX™ Capsid — — Ara Parseghian Medical Research Fund, a non-profit organization dedicated to finding a treatment …
Tag
Showing: 1 - 1 of 1 RESULTS